Drug Profile
Research programme: therapeutics agents - Otsuka Pharmaceutical/X-Chem
Latest Information Update: 28 Jan 2022
Price :
$50
*
At a glance
- Originator X-Chem
- Developer Otsuka Pharmaceutical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Jan 2022 No recent reports of development identified for research development in Unspecified in Japan
- 28 Jan 2022 No recent reports of development identified for research development in Unspecified in USA
- 20 May 2020 Otsuka Pharmaceutical in-licenses DNA-encoded library (DEXTM) screening and informatics platform from X-Chem